Secukinumab for the Treatment of Deficiency of Interleukin 36 Receptor Antagonist in an Adolescent

被引：20
|
作者：
Molho-Pessach, Vered [1 ,2 ]
Alyan, Rinad [1 ]
Gordon, Danielle [3 ]
Jaradat, Hussein [4 ]
Zlotogorski, Abraham [1 ,2 ]
机构：
[1] Hadassah Hebrew Univ, Med Ctr, Dept Dermatol, Jerusalem, Israel
[2] Hadassah Hebrew Univ, Ctr Genet Dis Skin & Hair, Med Ctr, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[4] Palestinian Minist Hlth, Jenin Hlth Directorate, Palestinian Author, West Bank, Ramallah, Palestine
来源：
JAMA DERMATOLOGY | 2017年 / 153卷 / 05期
关键词：
GENERALIZED PUSTULAR PSORIASIS;
D O I：
10.1001/jamadermatol.2016.5705
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：473 / 475
页数：3
相关论文
共 50 条
  • [31] Response to Interleukin (IL)-17 Inhibition in an AdolescentWith Severe Manifestations of IL-36 Receptor Antagonist Deficiency (DITRA)
    Cordoro, Kelly M.
    Ucmak, Derya
    Hitraya-Low, Maria
    Rosenblum, Michael D.
    Liao, Wilson
    JAMA DERMATOLOGY, 2017, 153 (01) : 106 - 108
  • [32] Deficiency of the Interleukin-36 Receptor Antagonist (DITRA) disrupts dermal immune homeostasis predisposing to severe psoriatic disease.
    Fernandez, Paloma Narros
    Basavarajappa, Shrikanth Chomanahalli
    Loughnane, Heather
    Bless, Larissa
    Santana, Yasmina Hernandez
    Walsh, Patrick T.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1234 - 1234
  • [33] Generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist successfully treated with granulocyte and monocyte adsorption apheresis
    Sugiura, K.
    Haruna, K.
    Suga, Y.
    Akiyama, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (12) : 1835 - 1836
  • [34] Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist
    Bresnihan, B
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 96 - 98
  • [35] Response to: 'Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist' by Cherqaoui et al
    Bonekamp, Nadia
    Caorsi, Roberta
    Frenkel, Joost
    Gattorno, Marco
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (12)
  • [36] Interleukin-36 receptor antagonist alleviates airway inflammation in asthma via inhibiting the activation of Interleukin-36 pathway
    Liu, Xin-Guang
    Li, Jing
    Zheng, Lu-Jun
    Han, Bo
    Huang, Fang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81
  • [37] Serum Levels of Interleukin-36 Receptor Antagonist in Behcet's Patients
    Unsal, Pelin
    Cerci, Pamir
    Acikgoz, Sukru Alper
    Keskin, Goksal
    Olmez, Umit
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [38] Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients
    Hoelsken, Stefanie
    Krefting, Frederik
    Muehlhaus, Senta
    Bese, Daniela
    Schedlowski, Manfred
    Sondermann, Wiebke
    PSORIASIS-TARGETS AND THERAPY, 2025, 15 : 9 - 22
  • [39] Chronic Recurrent Multifocal Osteomyelitis and Deficiency of Interleukin-1-receptor Antagonist
    Sakran, Waheeb
    Shalev, Stavit A.
    El-Shanti, Hatem
    Uziel, Yosef
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (01) : 94 - 94
  • [40] Safety and Efficacy of Anakinra in Patients with Deficiency of Interleukin-1 Receptor Antagonist
    Montealegre, Gina A.
    de Jesus, Adriana Almeida
    Chapelle, Dawn C.
    Dancey, Paul
    Frenkel, Joost
    van Royen-Kerkhoff, Annet
    Herzog, Ronit
    Ciocca, Giovanna
    Rivas-Chacon, Rafael F.
    Reed, Ann M.
    Plass, Nicole
    Aksentijevich, Ivona
    Ferguson, Polly J.
    Hill, Suvimol C.
    Cowen, Edward
    Goldbach-Mansky, Raphaela T.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S861 - S861
12345